These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22232961)

  • 1. [Musculoskeletal manifestations in lysosomal storage diseases].
    Kovac I
    Reumatizam; 2011; 58(2):182-4. PubMed ID: 22232961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musculoskeletal manifestations of lysosomal storage disorders.
    Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM
    Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of lysosomal storage diseases: update and perspectives].
    Lara-Aguilar RA; Juárez-Vázquez CI; Medina-Lozano C
    Rev Invest Clin; 2011; 63(6):651-8. PubMed ID: 23650678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musculoskeletal complications encountered in the lysosomal storage disorders.
    Pastores GM
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):937-47. PubMed ID: 19028373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for lysosomal storage disorders.
    Meikle PJ; Grasby DJ; Dean CJ; Lang DL; Bockmann M; Whittle AM; Fietz MJ; Simonsen H; Fuller M; Brooks DA; Hopwood JJ
    Mol Genet Metab; 2006 Aug; 88(4):307-14. PubMed ID: 16600651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lysosomal storage diseases - update and new therapeutic options].
    Schöpfer K; Miebach E; Beck M; Pitz S
    Klin Monbl Augenheilkd; 2011 Feb; 228(2):144-60. PubMed ID: 20309790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models.
    Brooks DA
    Mol Genet Metab; 1999 Oct; 68(2):268-75. PubMed ID: 10527678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly.
    vom Dahl S; Mengel E
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):619-28. PubMed ID: 20955964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musculoskeletal manifestations of mucopolysaccharidoses.
    Morishita K; Petty RE
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v19-25. PubMed ID: 22210666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatments and future perspectives: outcomes of intrathecal drug delivery.
    Dickson PI
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S124-7. PubMed ID: 20040323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current strategies in the management of lysosomal storage diseases.
    Heese BA
    Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy for lysosomal storage diseases.
    Ohashi T
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy and substrate reduction therapy in lysosomal storage disorders with neurological expression.
    Valayannopoulos V
    Handb Clin Neurol; 2013; 113():1851-7. PubMed ID: 23622408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
    Li M
    Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lysosomal storage diseases--an overview].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):128-32. PubMed ID: 21913413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders.
    Desnick RJ; Schuchman EH
    Nat Rev Genet; 2002 Dec; 3(12):954-66. PubMed ID: 12459725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral small molecule therapy for lysosomal storage diseases.
    Weinreb NJ
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():77-90. PubMed ID: 24380126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological small molecules for the treatment of lysosomal storage disorders.
    Smid BE; Aerts JM; Boot RG; Linthorst GE; Hollak CE
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1367-79. PubMed ID: 20942596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal storage diseases: cellular pathology, clinical and genetic heterogeneity, therapy.
    Reuser AJ; Kroos MA; Visser WJ; Willemsen R
    Ann Biol Clin (Paris); 1994; 52(10):721-8. PubMed ID: 7747880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrops fetalis: lysosomal storage disorders in extremis.
    Stone DL; Sidransky E
    Adv Pediatr; 1999; 46():409-40. PubMed ID: 10645471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.